URI
33
-7
EW
46
-7
F
40
-7
MTCH
33
-7
A
53
9
AIG
32
-3
NWSA
65
-8
AAPL
61
-7
GILD
49
-7
ILMN
26
-10
UAL
63
-9
LYB
34
-3
K
45
-5
HBAN
40
-11
HBI
50
-6
LEG
14
-7
DIS
66
-6
BBY
48
-2
VFC
54
-7
LRCX
56
-8
URI
33
-7
EW
46
-7
F
40
-7
MTCH
33
-7
A
53
9
AIG
32
-3
NWSA
65
-8
AAPL
61
-7
GILD
49
-7
ILMN
26
-10
UAL
63
-9
LYB
34
-3
K
45
-5
HBAN
40
-11
HBI
50
-6
LEG
14
-7
DIS
66
-6
BBY
48
-2
VFC
54
-7
LRCX
56
-8
Financhill
Back

Incyte Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
40

INCY
Incyte

Last Price:
66.72
Seasonality Move:
15.76%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.67
Seasonality Move:
5.39%
Sell
40
Incyte (INCY) is a Sell

Is Incyte a Buy, Sell or Hold?

  • The current Incyte [INCY] share price is $67.58. The Score for INCY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.66. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INCY Stock Price Chart

What is Incyte's stock price today?

  • The Incyte share price today is $67.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INCY is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

INCY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.15 Sell
Relative Strength Index (14 RSI): 37.18 Sell
Chaikin Money Flow: -1799413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.07 - 76.09) Sell
Bollinger Bands (100): (62.66 - 73.8) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.07 Sell
Chaikin Money Flow: -1141909 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.59 - 66.63) Sell
Bollinger Bands (100): (64.49 - 84.47) Sell

INCY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.41 Sell
20-day SMA: 72.27 Sell
50-day SMA: 72.12 Sell
200-day SMA: 63.21 Buy
8-day EMA: 70.21 Sell
20-day EMA: 71.95 Sell
50-day EMA: 71.52 Sell
200-day EMA: 65.94 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.11 Sell
20-day SMA: 65.41 Sell
50-day SMA: 66.85 Sell
200-day SMA: 79.13 Sell
8-day EMA: 65.86 Sell
20-day EMA: 65.82 Sell
50-day EMA: 67.81 Sell
200-day EMA: 77.26 Sell

Incyte Earnings Growth & INCY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.30 per share, and an increase next year of $4.72 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Incyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):